Latigo Biotherapeutics Inc (LTGO)

2026-08-07T15:45:33.000Z - 17 days ago

Latigo Biotherapeutics opens at $21, IPO priced at $18 per share

2026-08-07T14:11:23.000Z - 17 days ago

Latigo Biotherapeutics indicated to open at $20, IPO priced at $18

2026-08-07T03:00:35.000Z - 18 days ago

Latigo Biotherapeutics 19.2M share IPO priced at $18.00

2026-08-04T09:05:30.000Z - 20 days ago

Latigo Biotherapeutics 16M share IPO price range $16.00-$18.00

Aug 3, 2026, 8:25 AM EDT - 21 days ago

Latigo, BlossomHill launch US IPOs as biotech listings rebound

BLSM

Jul 29, 2026, 5:08 PM EDT - 26 days ago

Latigo Biotherapeutics Announces New England Journal of Medicine Publication of Positive LTG-001 Abdominoplasty Clinical Trial Results in Moderate-to-Severe Acute Pain

Jul 17, 2026, 1:01 PM EDT - 5 weeks ago

Acute and chronic pain relief biotech Latigo Biotherapeutics files for a $100 million IPO

Jul 17, 2026, 12:33 PM EDT - 5 weeks ago

Latigo Biotherapeutics IPO Registration Document (S-1)